| NCT ID | NCT02355457 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Condition | Acute Coronary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2013-07 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2013-07 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of the study is to investigate new cardiac biomarkers and algorithms to diagnose acute coronary syndrome in patients with suspected acute myocardial infarction.
Eligibility Criteria
Inclusion Criteria: * Symptoms suggestive of acute myocardial infarction * Ability to provide written informed consent in accordance with Good epidemiological Practice and local legislation * Individuals at least 18 years old Exclusion Criteria: \- Insufficient knowledge of the German language (able to understand and write the German language)
Contact & Investigator
Johannes Neumann, MD
PRINCIPAL INVESTIGATOR
UHZ
Frequently Asked Questions
Who can join the NCT02355457 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02355457 currently recruiting?
Yes, NCT02355457 is actively recruiting participants. Contact the research team at j.neumann@uke.de for enrollment information.
Where is the NCT02355457 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT02355457 clinical trial?
NCT02355457 is sponsored by Universitätsklinikum Hamburg-Eppendorf. The principal investigator is Johannes Neumann, MD at UHZ. The trial plans to enroll 5,000 participants.